Exposed surfaces of the body are protected by an array of antimicrobial peptides. Helix BioMedix, Inc. is developing this natural first line of defense into therapeutics capable of treating skin conditions such as acne, rosacea and cutaneous mycoses. In addition, for the prevention of infectious deceases caused by multi-resistant pathogens such as MRSA and Acinetobacter.

We have also adapted aspects of this innate defense system to generate other clinically important biological responses, such as cell proliferation and migration reduction of inflammation and stimulation of extracellular matrix.